Key facts
- It has raised $110.0M; the latest was Early Stage VC ($82.2M) in Feb 2025.
- Notable investors include Lapam Capital, Dragonball Capital, LAV (Lilly Asia Fund).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Enchannel Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Enchannel Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enchannel Medical
Operator of a cardiac electrophysiology device platform intended for precise mapping and targeted treatment of complex heart rhythm disorders. The company offers integrated contact and non-contact mapping capabilities, hybrid magnetic and impedance navigation, advanced AI-driven algorithms, and pulsed field ablation tools, enabling electrophysiologists in clinical and hospital settings to conduct more accurate diagnostics and improve patient outcomes through refined procedural control and treatment precision.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2020
- Website
- enchannel.com/
- Ownership
- Privately Held (backing)
Enchannel Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enchannel Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enchannel Medical in its N-PORT filings yet. We sweep new filings monthly.